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Abstract
Background: Activities of daily living in patients with chronic obstructive pulmonary disease (COPD) are limited by
exertional dyspnea and reduced exercise capacity. The aims of the study were to examine longitudinal changes in
peak oxygen uptake (V̇O2peak), peak minute ventilation (V̇Epeak) and breathing pattern over four years in a group of
COPD patients, and to examine potential explanatory variables of change.
Methods: This longitudinal study included 63 COPD patients, aged 44-75 years, with a mean forced expiratory
volume in one second (FEV1) at baseline of 51 % of predicted (SD = 14). The patients performed two
cardiopulmonary exercise tests (CPETs) on treadmill 4.5 years apart. The relationship between changes in V̇O2peak
and V̇Epeak and possible explanatory variables, including dynamic lung volumes and inspiratory capacity (IC), were
analysed by multivariate linear regression analysis. The breathing pattern in terms of the relationship between
minute ventilation (V̇E) and tidal volume (VT) was described by a quadratic equation, VT = a + b∙V̇E + c∙V̇E
2, for each
test. The VTmax was calculated from the individual quadratic relationships, and was the point where the first
derivative of the quadratic equation was zero. The mean changes in the curve parameters (CPET2 minus CPET1)
and VTmax were analysed by bivariate and multivariate linear regression analyses with age, sex, height, changes in
weight, lung function, IC and inspiratory reserve volume as possible explanatory variables.
Results: Significant reductions in V̇O2peak (p < 0.001) and V̇Epeak (p < 0.001) were related to a decrease in resting IC
and in FEV1. Persistent smoking contributed to the reduction in V̇O2peak. The breathing pattern changed towards a
lower VT at a given V̇E and was related to the reduction in FEV1.
Conclusion: Increasing static hyperinflation and increasing airway obstruction were related to a reduction in
exercise capacity. The breathing pattern changed towards more shallow breathing, and was related to increasing
airway obstruction.
Background
Activities of daily living in patients with chronic
obstructive pulmonary disease (COPD) are limited by
exertional dyspnea and reduced exercise capacity [1, 2].
Exertional dyspnea appears to be related to the increased
work of breathing associated with a restriction of tidal
volume (VT) expansion [3]. A reduction in exercise cap-
acity measured as peak oxygen uptake (V̇O2peak) has
been found to be related to ventilatory limitations [4, 5],
pulmonary gas exchange abnormalities [6], peripheral
muscle dysfunction [7, 8] or any combination of these
factors. COPD is a progressive disease with an increased
rate of decline in forced expiratory volume in one sec-
ond (FEV1) [9, 10]. However, the relationship between
FEV1 and V̇O2peak is considered weak, and lung function
by itself is a poor predictor of exercise capacity [11].
Studies of longitudinal changes in V̇O2peak, peak
minute ventilation (V̇Epeak) and breathing pattern in
COPD are scarce. As far as we know, the longitudinal
change in V̇O2peak has only been examined in one previ-
ous study [12]. A reduction in V̇O2peak over five years
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was found to be related to a reduction in maximal tidal
volume (VTmax) and V̇Epeak, and the decrease in V̇O2peak
was associated with the decrease in FEV1. However, only
male Japanese patients were included in that study and
the breathing pattern was not examined. We are not
aware of any studies that have examined the longitudinal
changes in V̇O2peak and breathing pattern in COPD pa-
tients of Caucasian origin including both genders.
The breathing pattern in terms of the relationship
between minute ventilation (V̇E) and VT during incre-
mental exercise has been described by Gallagher [13]. In
the first phase, there is an almost linear relationship be-
tween V̇E and VT. In the second phase, the increase in
V̇E is mainly caused by an increase in breathing fre-
quency (Bf ), and a smaller increase in VT. In the third
phase, the increase in V̇E is caused by an increase in Bf
only, and by the end of this phase, there can be a fall in
VT. Different methods have been suggested to describe
this relationship like the plateau of VT and its inflection
point [14], VTmax and VT at a V̇E of 30 L/min [15], VT at
given fractions of V̇Epeak [16] and the Hey plot [17]. We
have found that the V̇E-VT relationship can be satisfac-
torily described by a quadratic model in COPD patients
exercising on treadmill [18]. A quadratic model includes
all available data from the exercise test. However, longi-
tudinal changes in the breathing pattern as described by
this method have not been examined.
The aims of the present study were to examine
changes in exercise and ventilatory capacity and breath-
ing pattern over four years in COPD patients, and to
examine the relationship with variables that potentially
contribute to explain the changes. We hypothesized that
V̇O2peak and V̇Epeak would deteriorate during the obser-
vation period, that breathing pattern would be shallower
with a lower VTmax, and that the changes were related to
lung hyperinflation and airway obstruction.
Methods
Subjects
The current study included 63 patients from the Bergen
COPD Cohort Study (BCCS) who performed two
cardiopulmonary exercise tests (CPETs) with an average
follow-up time of 4.5 years (range 3-6 years). The BCCS
was a three year follow-up study (2006–2010) and inclu-
sion and exclusion criteria have been previously
published [19]. Summarised, all patients had a smoking
history of ≥ 10 pack-years, a post- bronchodilation FEV1
to forced vital capacity (FVC) ratio < 0.7 and a post-
bronchodilator FEV1 < 80 % of predicted value according
to Norwegian reference values [20]. All subjects in BCCS
were informed of the opportunity to participate in
pulmonary rehabilitation but were not otherwise actively
selected or recruited for rehabilitation. There were no
restrictions to treatment in the study period.
A total of 89 patients were enrolled to a 7- week
pulmonary rehabilitation program, including a total of
17 sessions, during the first two years of follow-up in
2006–2008. The first CPET was performed at start of
the program. The patients were invited to a second
CPET in 2011/2012. At that time 26 of the 89 patients
were deceased or disabled. The 63 included patients had
clinically stable COPD in stages II-IV according to the
Global Initiative for Chronic Obstructive Lung Disease
(GOLD) (GOLD 2007) [21] and age between 44–75
years. Exclusion criteria for exercise testing were major
cardiovascular disorders, a partial pressure of oxygen in
arterial blood less than 8 kPa at rest, or exacerbations
that required medical treatment during the last four
weeks prior to testing.
Ethics
The Western Norway Regional Research Ethics Commit-
tee approved the study. Participation in the study was
voluntary. Written and oral information was given and
written consent was obtained prior to inclusion.
Spirometry
Spirometry was conducted on a Viasys Masterscope
(Viasys, Hoechberg, Germany) before the CPETs accord-
ing to the ATS/ERS Standardization of Lung Function
Testing [22]. FEV1 and FVC were taken as the highest
values from at least three satisfactory expiratory
manoeuvers. The spirometer was calibrated before each
test with a 3-L calibration syringe. The changes in FEV1
(ΔFEV1) and FVC (ΔFVC) were calculated as FEV1 or
FVC at CPET2 minus FEV1 or FVC at CPET1.
Cardiopulmonary exercise test
The patients completed two incremental CPETs to their
symptom-limited maximum on a treadmill (Woodway,
model: PPS 55 med Weiss, Weil am Rhein, Germany).
The exercise protocol was a modified Bruce protocol
[23, 24]. The test started with rest in the standing
position for 2 min. The warm-up phase lasted for 1 min
with a walking speed of 1.5 km h−1. The protocol has 20
stages, all lasting for one minute. The first stage was at
1.5 km/h with an inclination of 0 %. In stage 2, the speed
was the same as in stage 1 with an inclination of 5 %.
From stage 3–5, the speed increased with 0.6 km/h and
the inclination was 9, 10 and 11 %, respectively. From
stage 6–13, the speed increased with 0.6–0.7 km/h and
the inclination with 1 %. From stage 13–14, the speed
increased with 0.4 km/h, and the inclination increased
with 1 %. Finally, from stage 15–20, the speed was
increasing with 1 km/h each minute and the inclination
was the same as in stage 14. The warm-up was not
counted into the exercise time.
Frisk et al. BMC Pulmonary Medicine  (2015) 15:93 Page 2 of 11
Blood pressure, electrocardiography (GE healthcare, Car-
dio Soft EKG, Freiburg, Germany) and pulse oximetry were
monitored at rest, continuously during the test and for
3 min into the recovery phase. A tight-fitting oronasal mask
was adjusted to each patient and checked for leaks before
starting the exercise. The integrated exercise testing system
(Care Fusion, Vmax Spectra 229, Hochberg, Germany) was
calibrated every morning and immediately before each test.
The VT, Bf, oxygen uptake (V̇O2), carbon dioxide output
(V̇CO2), and heart rate (HR) were measured on a breath by
breath basis and averaged over 20 s intervals. V̇E and VT
were corrected to the body temperature pressure saturated
(BTPS) condition, and V̇O2 and V̇CO2 to the standard
temperature pressure dry (STPD) condition.
The patients graded their level of dyspnea and leg dis-
comfort by Borg CR10 Scale [25]. In order to measure
dynamic hyperinflation during exercise, serial measure-
ments of inspiratory capacity (IC) were performed [5].
Measurements were taken at rest, every second minute
during exercise and at peak exercise. The change in IC
(ΔIC) during each of the CPETs was calculated as IC at
rest minus IC at peak exercise. The change in dynamic
hyperinflation between the CPETs (ΔICdynamic) was
calculated as ΔIC at CPET2 minus ΔIC at CPET1. The
difference in IC at rest (ΔICrest) was calculated as IC at
rest at CPET2 minus IC at rest at CPET1. The differ-
ences in V̇O2peak (ΔV̇O2peak) and V̇Epeak (ΔV̇Epeak) were
calculated in the same way. Inspiratory reserve volume
(IRV) was calculated for each of the two CPETs as the
difference between IC at the end of the test minus the
maximal VT. The difference in IRV (ΔIRV) was calcu-
lated as IRV at CPET2 minus IRV at CPET1. The
estimated MVV was calculated as FEV1 × 35 [26].
Self-reported physical activity was recorded at baseline
and after one and three years in the BCCS [27]. Two
questions were related to spare time physical activity,
one for strenuous and one for light physical activity. The
delineation between strenuous and light was whether
the activity resulted in breathlessness and sweating or
not. The response categories were none, less than 1 h
per week, 1-2 h per week and three or more hours per
week. These questions are previously validated [28, 29].
Data on exacerbations and smoking habits were
recorded at the time for the CPETs.
Statistical analyses
Descriptive statistics were used to characterize the study
population (mean, standard deviation (SD), median and
percent). Independent samples t-tests for continuous
variables and Pearson chi square- tests for categorical
variables were used to compare patients’ characteristics
and CPET responses to patients who only performed
one CPET with those that completed both. Paired
samples t-tests were used to analyze the longitudinal
change in pulmonary function, exercise capacity and
breathing pattern in the patients who completed both
CPETs. Pearson correlation coefficient was used to
calculate the linear relationship between the yearly
change in V̇O2peak and FEV1. The relationships between
ΔV̇O2peak or ΔV̇Epeak and potential explanatory variables
were analysed by bivariate (unadjusted) and multivariate
(adjusted) linear regression analyses. Investigated vari-
ables were age, sex, height, baseline V̇O2peak or baseline
V̇Epeak, smoking during follow-up, ΔFEV1, ΔFVC,
Δweight, ΔICrest, ΔICdynamic, self-reported physical activ-
ity, exacerbations and time between the tests. ΔFVC was
not included in the multivariate regression analysis,
because it is an intermediary variable with ΔFEV1 and
the outcome variable.
A quadratic model (VT = a + b∙V̇E + c∙V̇E
2) was used to
describe the relationship between V̇E and VT during
incremental exercise. The goodness-of-fit for the individ-
ual patient specific regression analysis was evaluated by
the adjusted coefficient of determination (adjusted R2)
and the F statistic. For the latter a p-value < 0.05 was
required for inclusion of the patient in further analysis.
These analyses were done for each individual patient in
CPET1 and CPET2.
The mean values for the curve parameters the
constant (intercept) (a), the linear coefficient (slope) (b)
and the quadratic coefficient (curvature) (c) were calcu-
lated. VTmax was calculated from the individual quad-
ratic relationships, and was the point where the first
derivative of the quadratic equation was zero. The mean
change (CPET2 minus CPET1) in the curve parameters
and the change in VTmax (ΔVTmax) were analysed by
bivariate and multivariate linear regression analysis with
age, sex, height, Δweight, ΔFEV1, ΔIRV, ΔICrest, and
ΔICdynamic as explanatory variables.
Estimated regression coefficients are presented with
95 % confidence intervals and p-values. The significance
level was set at 0.05. The data analyses were performed
using IBM SPSS Statistics 21 (SPSS Inc. Chicago, Illinois,
USA).
Results
The baseline characteristics of the study population and
the peak responses to the incremental exercise test at
baseline are shown in Table 1. The patients’ mean age
(SD) was 61 (6) years, 56 % were males and mean FEV1
in percent of predicted values was 51 (14) %. The 26
patients who only performed the first CPET were older,
had lower lung function and lower peak responses at the
CPET (Table 1).
Forty patients (63 %) remained in the same GOLD
stage during the follow-up, while eight (13 %) patients
had improved GOLD stage, six from stage III to II and
two from stage IV to III, respectively. Fifteen patients
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(24 %) had changed to a worse GOLD stage, eight from
stage II to III and seven from stage III to IV.
Longitudinal changes in exercise and ventilatory capacity
FEV1, FVC, V̇O2peak and V̇Epeak decreased significantly
during the follow-up period (Table 2), while the exercise
time on treadmill remained constant. The Borg dyspnea
score was not significantly different. The mean (SD)
decline in FEV1 was 34 (66) mL∙yr
−1, (p < 0.001) and in
V̇O2peak, 50 (68) mL · min
−1 · yr−1 (p < 0.001). The decline
in V̇O2peak and FEV1 during the observation period
correlated moderately (r = 0.43, p < 0.001) (Fig. 1).
The reduction in V̇O2peak was larger in subjects with a
higher baseline V̇O2peak (p < 0.001) and with a larger
reduction in ΔICrest (p = 0.002) (Table 3). Furthermore
age (p = 0.023), ΔFEV1 (p = 0.031) and smoking during
Table 1 Baseline characteristics of the study sample (n = 63) compared with patients only assessed at baseline (n = 26)
Variables Completed one CPET
n = 26
Completed two CPETs
n = 63
Group diff.
p-value
Sex, male/female n (%) 18/8 (69/31) 35/28 (56/44) 0.232
Age (years) 64.4 ± 5.8 61.2 ± 6.2 0.028
Smoking status n (%) 0.471
Current 9 (35) 27 (43)
Former 17 (65) 36 (57)
Pack years 38 ± 19 43 ± 26 0.380
Height (m) 1.72 ± 0.1 1.71 ± 0.1 0.540
Weight (kg) 72.8 ± 20.7 76.4 ± 17.5 0.406
BMI (mean, kg · m−2) 24.4 ± 5.4 26.3 ± 4.9 0.108
FEV1 (% pred.) 38.2 ± 11.4 51.4 ± 13.5 <0.001
FVC (% pred.) 83.5 ± 20.6 90.1 ± 17.2 0.120
FEV1/FVC (%) 36.4 ± 7.6 46.4 ± 10.8 <0.001
ICrest (L) 1.91 ± 0.50 2.36 ± 0.75 0.006
ΔIC(L) 0.30 ± 0.28 0.41 ± 0.40 0.232
GOLD category 0.001
II n (%) 5 (19) 34 (54)
III n (%) 14 (54) 26 (41)
IV n (%) 7 (27) 3 (5)
mMRC dyspnea grade 1.6 ± 0.9 1.3 ± 1.2 0.316
Experienced1≥ 2 exacerbations last year 0.402
No n (%) 18 (69) 49 (78)
Yes n (%) 8 (31) 14 (22)
Exercise time (min) 4.78 ± 1.66 6.44 ± 1.88 <0.001
V̇O2peak (L ∙ min
−1) 1.09 ± 0.31 1.57 ± 0.57 <0.001
V̇CO2peak (L ∙ min
−1) 1.08 ± 0.38 1.65 ± 0.69 <0.001
V̇Epeak (L ∙ min
−1) 40.2 ± 13.3 53.8 ± 19.2 <0.001
HRpeak (bpm) 125 ± 21 138 ± 20 0.009
RER 0.98 ± 0.12 1.03 ± 0.12 0.047
Dyspnea (Borg Scale) 8.6 ± 1.7 9.0 ± 1.6 0.481
Leg discomfort (Borg Scale) 5.5 ± 3.4 5.6 ± 2.8 0.905
SpO2 start (%) 96.8 ± 3.4 97.1 ± 2.2 0.546
SpO2 end (%) 89.9 ± 6.3 92.8 ± 5.0 0.024
Data are presented as mean ± SD, unless otherwise stated. Chi square for categorical variables and independent t-test for continuous variables. CPET:
cardiopulmonary exercise test; BMI: body mass index; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; ICrest: resting inspiratory capacity;
ΔIC: inspiratory capacity at rest minus IC at the end of the test; GOLD: Global Initiative for Chronic Obstructive Lung Disease; mMRC: modified Medical Research
Council. V̇O2peak: peak oxygen uptake per minute; V̇CO2peak: peak carbon dioxide production per minute V̇Epeak: peak minute ventilation per minute; HRpeak: peak
heart rate; RER: respiratory exchange ratio; SpO2: oxygen saturation
1Exacerbations requiring either hospitalization with oral antibiotics or oral steroids
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follow-up (p = 0.021) were found to be related to the
change in V̇O2peak. ΔV̇Epeak was related to ΔICrest
(p = 0.005), ΔFEV1 (p = 0.023) and baseline V̇Epeak
(p = 0.002) (Table 3). Gender was not associated with the
reduction in V̇O2peak or V̇Epeak.
Self-reported physical activity during follow-up as
reported in Bergen COPD Cohort Study and exacerba-
tions were not related to the longitudinal changes in
V̇O2peak or V̇Epeak (Table 3).
Longitudinal changes in breathing pattern
The quadratic model described the relationship between
V̇E and VT in 61 of 63 patients at CPET1 and at 59 of 63
patients in CPET2. In these subjects the p-value of the
F-statistics for the quadratic model was <0.05 and the R2
ranged from 0.35 to 0.99 (median 0.90) at CPET1, and
from 0.40 to 0.98 (median 0.90) at CPET2. A random set
of three individual responses from CPET1 and CPET2
are shown in Fig. 2. For the six excluded patients the
goodness of fit was not statistically significant and the
exercise time was short with few observations. The
means of the estimated constant (a), the linear coeffi-
cient (b) and the quadratic coefficient (c) changed
significantly from CPET1 to CPET2 (Table 2). The linear
coefficient (b) increased (p = 0.007) and the quadratic
coefficient (c) decreased (p = 0.002). The changes in the
Table 2 Pulmonary function and peak responses to cardiopulmonary exercise tests at baseline and 4.5 years apart
Variables CPET 1
n = 63
CPET 2
n = 63
Change CPET2
minus CPET1
p-value
Sex, male/female (n) 35/28
Weight (kg) 76.4 ± 17.5 76.0 ± 17.4 −0.4 ± 5.2 0.599
FEV1(L) 1.60 ± 0.53 1.46 ± 0.57 −0.15 ± 0.28 <0.001
FEV1 (% pred) 51.4 ± 13.5 48.0 ± 14.8 −3.4 ± 9.5 0.006
FVC (L) 3.47 ± 0.89 3.14 ± 0.86 −0.34 ± 0.50 <0.001
FVC (% pred) 90.1 ± 17.2 82.8 ± 15.3 −7.4 ± 14.7 <0.001
FEV1/FVC (%) 46.4 ± 10.8 46.0 ± 11.2 −0.4 ± 0.05 0.549
Exercise time (min) 6.44 ± 1.88 6.44 ± 2.18 −0.01 ± 1.61 0.980
V̇O2peak (L ∙ min
−1) 1.57 ± 0.57 1.36 ± 0.54 −0.22 ± 0.29 <0.001
V̇CO2peak (L ∙ min
−1) 1.65 ± 0.69 1.34 ± 0.67 −0.31 ± 0.37 <0.001
V̇Epeak/MVV 0.98 ± 0.22 0.94 ± 0.19 −0.03 ± 0.20 0.196
V̇Epeak (L ∙ min
−1) 53.8 ± 19.2 47.3 ± 19.6 −6.5 ± 11.6 <0.001
VTmax (L)
2 1.71 ± 0.51 1.48 ± 0.43 −0.23 ± 0.41 <0.001
HRpeak (bpm) 138 ± 20 133 ± 19 −5 ± 14 0.004
RER 1.03 ± 0.12 0.96 ± 0.14 −0.08 ± 0.11 <0.001
Dyspnea (Borg Scale) 9.0 ± 1.6 8.7 ± 1.6 −0.3 ± 1.8 0.327
Leg discomfort (Borg Scale) 5.6 ± 2.8 5.9 ± 3.0 0.3 ± 2.8 0.651
ICrest 2.36 ± 0.75 2.21 ± 0.78 −0.13 ± 0.48 0.039
ΔIC(L) 0.41 ± 0.40 0.46 ± 0.33 0.05 ± 0.38 0.208
IRV (L) 0.44 ± 0.37 0.38 ± 0.26 −0.05 ± 0.34 0.233
MVV (L ∙ min−1) 56.0 ± 18.6 51.0 ± 20.1 −5.1 ± 9.8 <0.001
SpO2 start (%) 97.1 ± 2.2 95.9 ± 2.5 −1.2 ± 3.2 0.004
SpO2 end (%) 92.8 ± 5.1 89.6 ± 5.1 −3.2 ± 4.4 <0.001
Curve parameters
Intercept (a)1 -0.05 (0.47) −0.18 (0.44) -0.13 (0.46) 0.032
Slope (b)1 0.063 (0.032) 0.076 (0.035) 0.014 (0.037) 0.007
Curvature (c)1 −0.00071 (0.00059) −0.00105 (0.00079) −0.00036 (0.00077) 0.002
Data are presented as mean ± SD, unless otherwise stated. Independent t-test for continuous variables
CPET: cardiopulmonary exercise test; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; V̇O2peak: peak oxygen uptake per minute;
V̇CO2peak: peak carbon dioxide production per minute; V̇Epeak: peak minute ventilation per minute; MVV: maximal voluntary ventilation (FEV1x35)
VTmax: maximal tidal volume; HRpeak: peak heart rate; RER: respiratory exchange ratio; ICrest: resting inspiratory capacity; ΔIC: IC at rest minus IC at the end
of the test; IRV: inspiratory reserve volume; SpO2: oxygen saturation
1The relationship between ventilation (V̇E) and tidal volume (VT) was described by a quadratic model (VT = a + b·V̇E + c·V̇E
2). 2VTmax was calculated from the
individual quadratic relationships, and was the point where the first derivative of the quadratic equation was zero
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curve parameters were all related to ΔFEV1, but not to
the other possibly explanatory variables (Table 4).
Maximal VT was achieved at a lower V̇E.
The VTmax decreased significantly from CPET1 to CPET2
(p < 0.001) (Table 2). In the multivariate linear regression
analysis, ΔVTmax was significantly related to the reduction
in FEV1 (B = 0.429, CI: 0.106–0.751, p < 0.010), the reduc-
tion in ICrest (B = 0.325, CI: 0.053–0.596, p < 0.020) and the
baseline VTmax (B =–0.471, CI: –0.662––0.281, p < 0.01).
Discussion
The major findings of this study of a group of COPD
patients who were followed over a mean time of 4.5 years
were a reduction in V̇O2peak and V̇Epeak which were
related to a decrease in resting IC and FEV1, and persist-
ent smoking during the observation period. The breath-
ing pattern changed towards a lower VTmax and a lower
VT at a given V̇E. The reduction in FEV1 was related to
the changes in the curve parameters describing the
breathing pattern.
The mean reduction in V̇O2peak was 50 (SD = 68)
mL∙min−1∙yr−1, which was slightly higher than the
decline in V̇O2peak of 32 mL∙min
−1∙yr−1 in male COPD
patients reported by Oga et al. [12]. In our study, both
genders were included, but the reduction in V̇O2peak or
V̇Epeak was not associated with gender. The reduction in
resting IC and FEV1, baseline V̇O2peak, smoking during
follow-up and age were all found to be related to the
change in V̇O2peak. As shown in Fig. 1 the association
between the changes in FEV1 and V̇O2peak was rather
weak with large interindividual variation. The strongest
associations were found for resting IC and baseline
V̇O2peak. Total lung capacity (TLC) was not measured,
and we are not aware of any studies having described
the longitudinal change in TLC in COPD patients. Based
on data from cross-sectional studies of COPD patients,
TLC is expected to remain unaltered or slightly
increased [30–32]. Thus, there is a possibility that the
increase in static hyperinflation as estimated by resting
IC is underestimated. There were no significant differ-
ences in dynamic hyperinflation between CPET1 and
CPET2. Without knowledge about TLC changes in
dynamic hyperinflation may have been obscured. Theor-
etically, dynamic hyperinflation is likely important since
it is associated with increased work of breathing and
dyspnea [1, 33].
The exercise time was the same at the two CPETs,
which can indicate better working economy, even
though V̇O2peak and lung function decreased signifi-
cantly. The respiratory exchange ratio and V̇CO2peak
were lower at the second CPET, whereas maximal Borg
dyspnea score was not significantly different at the two
CPETs. These observations are consistent with previous
studies showing that laboratory-based constant work
rate tests can be more sensitive demonstrating improve-
ments after interventions than V̇O2peak [11, 34].
We described the breathing pattern in the individual
patient by a quadratic relationship between V̇E and VT.
The relationship could be satisfactorily described by the
model in the majority of the subjects, and the model
accounts for all observations throughout the exercise
test. The limitations with other methods [14–17] are
that all observed data from the exercise test are not
included in the analyses. O’Donnell et al. [14] has
described the relationship between V̇E and VT during
exercise as linear until an inflection point. After this
point, further increase in V̇E is accomplished by an
increase in Bf. The inflection point is determined “by
eye” by two or three persons independently of each
other [14, 17]. When we examined our exercise data, it
was not obvious to see where an inflection point could
occur. In a quadratic model, which is analysed mathem-
atically, the curve parameter c in the equation will be
related to a “perceived” inflection point as it describes
the “sharpness” of the curvature, and the VTmax can be
calculated by derivation of the equation. By using this
method determinations of the curve parameters will not
be influenced by intra-and/or inter observer reliability.
Another consideration is that during an incremental ex-
ercise test, there will be a gradual transition between the
phases as described by Gallagher [13], and determining a
cut-off point where the change from one phase to the
other takes place, is not exactly defined. The changes in
Fig. 1 The relationship between change in V̇O2peak and change in
FEV1 between the two cardiopulmonary exercise tests (CPET).
V̇O2peak: Peak oxygen uptake. ΔV̇O2peak: V̇O2peak at CPET2 minus
V̇O2peak at CPET1. FEV1: Forced expiratory volume in 1 sec. Δ FEV1: FEV1
at CPET2 minus FEV1 at CPET1. R
2: The coefficient of determination
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the curve parameters describing the breathing pattern
were found to be related to the change in FEV1.
The time constant for the lung is increased in COPD
due to both increased resistance and compliance. Dy-
namic hyperinflation in response to increasing ventila-
tory demands is a necessary compensatory mechanism
allowing complete respiratory cycles. Resistance and
compliance are both related to FEV1, but we did not find
any relationships between changes in breathing pattern
and changes in IC or IRV after adjusting for FEV1.
Study limitations
The BCCS, which this study sample is a part of, made no
restrictions to treatment in the study period, and the
Table 3 The relationships between changes in peak oxygen uptake and peak minute ventilation and explanatory variables
Variable Unadjusted Adjusted p-value
B p-value B St.B* 95 % CI
ΔV̇O2peak (L ∙ min
−1)
Age (years) −0.006 0.273 −0.011 −0.238 −0.020–−0.002 0.023
Sex −0.146 0.042 0.022 0.039 −0.110–0.155 0.737
Height (m) −0.652 0.145
V̇O2peak at baseline (L ∙ min
−1) −0.178 0.004 −0.260 −0.515 −0.379–−0.141 <0.001
Smoking during follow-up −0.108 0.144 −0.139 −0.240 −0.257–−0.021 0.021
ΔFEV1 (L) 0.440 <0.001 0.254 0.251 0.024–0.484 0.031
ΔFVC (L) 0.271 <0.001
Δ Weight (kg) −0.004 0.604
ΔICrest (L) 0.317 <0.001 0.294 0.492 0.110–0.478 0.002
ΔICdynamic (L) 0.202 0.037 −0.105 −0.140 −0.315–0.105 0.320
Strenuous physical activity 0.020 0.593
Light physical activity 0.079 0.131
Exacerbations −0.100 0.166
Time between CPET1 and CPET2 0.005 0.907
R2 = 0.567
ΔV̇Epeak (L ∙ min
−1)
Age (years) −0.075 0.756 −0.131 −0.070 −0.545–0.283 0.528
Sex −2.484 0.404 3.180 0.163 −2.111–9.732 0.203
Height (m) −3.447 0.848
V̇Epeak at baseline (L ∙ min
−1) −0.163 0.032 −0.259 −0.422 −0.415–−0.103 0.002
Smoking during follow-up −3.506 0.249
ΔFEV1 (L) 19.220 <0.001 11.845 0.285 1.699–21.990 0.023
ΔFVC (L) 11.626 <0.001
Δ Weight (kg) −0.324 0.254
ΔICrest (L) 13.030 <0.001 12.135 0.497 3.759–20.510 0.005
ΔICdynamic (L) 11.109 0.004 −4.219 −0.137 −13.748–5.310 0.379
Strenuous physical activity 0.984 0.512
Light physical activity 2.241 0.297
Exacerbations −4.775 0.104
Time between CPET1 and CPET2 −0.299 0.870
R2 = 0.447
95 % confidence interval (CI) examined by linear regression in bivariate and multivariate analyses
CPET: cardiopulmonary exercise test; V̇O2peak: peak oxygen uptake per minute; ΔV̇O2peak: V̇O2peak at CPET2 minus V̇O2peak at CPET1; FEV1: forced expiratory volume
in one second; ΔFEV1: FEV1 at CPET2 minus FEV1 at CPET1; FVC: forced vital capacity; ΔFVC and Δweight were calculated like ΔFEV1. IC: inspiratory capacity. ΔICrest
was calculated as IC at rest at CPET2 minus IC at rest at CPET1. ΔIC was calculated as IC at rest minus IC at the end of the test for both CPET1 and CPET2.
ΔICdynamic was calculated as ΔIC at CPET2 minus ΔIC at CPET1; V̇E: minute ventilation per minute; ΔV̇Epeak: peak V̇E at CPET2 minus peak V̇E at CPET1; R
2: The
coefficient of determination
*St.B: Standardised beta
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participants were free to receive medication or other treat-
ment prescribed by their physician. Since the included pa-
tients participated in a pulmonary rehabilitation program
after the first CPET, this was a selected group and the
results cannot be generalized to the common COPD popu-
lation. One of the major effect of pulmonary rehabilitation
is to increase exercise tolerance and reduce shortness of
breath, but since there was no maintenance program, the
effect of the rehabilitation probably would be negligible
after four years. The reduction in FEV1 in our patients was
34 (SD = 66) mL · year−1, which was not different from the
mean rate of decline in FEV1 of 33 mL · year
−1 in the
Fig. 2 A random set of three individual responses from the two CPETs performed 4.5 years apart. CPET: Cardiopulmonary exercise test
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Table 4 The relationships between the change in the curve parameters1 and explanatory variables (CPET2 minus CPET1)
Unadjusted Adjusted
Variable B p-value B St.B* 95 % CI p-value
Intercept1 (Curve parameter a)
Age 0.002 0.803 −0.0003 −0.004 −0.015–0.014 0.966
Sex −0.089 0.468 −0.126 −0.138 −0.312–0.060 0.180
Height 0.145 0.844
abaseline −0.545 <0.001 −0.573 −0.588 −0.769–−0.376 <0.001
Δweight −0.002 0.881
ΔFEV1 0.601 0.005 0.762 0.461 0.376–1.149 <0.001
ΔFVC 0.427 0.001
ΔICrest (L) 0.116 0.374 −0.052 −0.053 −0.365–0.262 0.743
ΔICdynamic (L) −0.025 0.882 −0.203 −0.166 −0.561–0.156 0.262
ΔIRV −0.147 0.416
R2 = 0.507
Slope1 (Curve parameter b)
Age −0.0003 0.725 0.00003 0.006 −0.001–0.001 0.959
Sex 0.002 0.860 0.012 0.159 −0.005–0.029 0.177
Height −0.059 0.311
bbaseline −0.568 <0.001 −0.588 −0.510 −0.854–−0.322 <0.001
Δweight 0.002 0.862
ΔFEV1 −0.046 0.009 −0.050 −0.373 −0.085–−0.015 0.006
ΔFVC −0.032 0.003
ΔICrest (L) −0.008 0.429 −0.001 −0.008 −0.029–0.028 0.963
ΔICdynamic (L) 0.005 0.734 0.018 0.183 −0.014–0.050 0.265
ΔIRV −0.023 0.119 R2 = 0.393
Curvature1 (Curve parameter c)
Age −4.8x10−6 0.774 −7.2x10−6 −0.061 −0.00004–0.00002 0.643
Sex −7.3x10−5 0.746 −2.5x10−5 −0.016 −0.0004–0.0004 0.901
Height 0.001 0.586
cbaseline −0.406 0.033 −0.345 −0.254 −0.695–0.006 0.054
Δweight 7.5x10−6 0.762 B
ΔFEV1 0.001 0.001 0.001 0.372 0.0002–0.002 0.013
ΔFVC 0.001 <0.001
ΔICrest (L) 0.0005 0.025 0.0004 0.268 −0.00002–0.001 0.192
ΔICdynamic (L) 0.0001 0.651 −0.001 −0.249 −0.001–0.0002 0.179
ΔIRV −0.0003 0.280
R2 = 0.315
95 % confidence interval (CI) examined by linear regression in bivariate and multivariate analyses
CPET: cardio pulmonary exercise test; Δweight: weight at CPET2 minus weight at CPET1; FEV1: forced expired volume in one second, ΔFEV1: FEV1 at CPET2 minus
FEV1 at CPET1; FVC: forced vital capacity; ΔFVC: FVC at CPET2 minus FVC at CPET1; IC: inspiratory capacity; ΔICrest was calculated as IC at rest at CPET2 minus IC at
rest at CPET 1; ΔIC was calculated as IC at start of the test minus IC at the end of the test; ΔICdynamic was calculated as ΔIC at CPET2 minus ΔIC at CPET1; IRV:
inspiratory reserve volume; ΔIRV was calculated as IRV at CPET2 minus IRV at CPET1; abaseline: curve parameter a at baseline; bbaseline: curve parameter b at
baseline; cbaseline: curve parameter c at baseline; R
2: The coefficient of determination
1 The relationship between ventilation (V̇E) and tidal volume (VT) was described by a quadratic model (VT = a + b·V̇E + c·V̇E
2), and the a, b, and c were calculated as
the difference between CPET2 minus CPET1
*St.B: Standardised beta
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ECLIPSE study [10]. Without participation in pulmonary
rehabilitation, the decline in V̇O2peak and V̇Epeak could have
been larger, resulting in an even stronger association with
the predictors.
Self-reported physical activity was not measured syn-
chronized with the second CPET, but was part of the
data collection at baseline, and at one and three year
follow-up in BCCS. We have previously shown that pa-
tients who participated in pulmonary rehabilitation were
more physically active than those who had not [27]. We
assume that the physical activity level would not be sub-
stantially different from this recording.
The dropout rate from baseline to follow-up after a mean
time of 4.5 years was 29 %. The patients were lost to
follow-up mainly because of death or disease severity. In
the study of Oga et al. [12] the dropout rate was 51 %. In
longitudinal observational studies with the 6 min walking
distance as the main outcome and a follow-up period of
3–5 years, the dropout rate varied between 31–34 %
[35–37]. With a progressive disease, an increasing dropout
rate over time is unavoidable and as compared with
previous studies our dropout rate is not considered high.
Conclusions
There was a significant reduction in V̇O2peak and V̇Epeak
over 4.5 years in this group of COPD patients. The changes
were related to an increase in lung hyperinflation and a re-
duction in FEV1 along with persistent smoking during the
study period. The breathing pattern changed towards a
lower VTmax and a lower VT at a given V̇E and the reduc-
tion in FEV1 predicted these changes. The findings indicate
that optimal treatment of airway obstruction and lung
hyperinflation, and smoking cessation are all important in
optimizing functional capacity in COPD along with physical
training programs.
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